Salicylato[tris(N-methylbenzimidazol-2-ylmethyl)amine]zinc(II) perchlorate dimethylformamide sesquisolvate
暂无分享,去创建一个
In the title complex, [Zn(C7H5O3)(C27H27N7)]ClO4·1.5C3H7NO, the ZnII atom is five-coordinated by four N atoms from a tris(N-methylbenzimidazol-2-ylmethyl)amine ligand and one O atom from a salicylate ligand in a distorted trigonal-bipyramidal geometry (τ parameter = 0.84), with approximate molecular C 3 symmetry. One dimethylformamide molecule lies on a general position and is disordered over two coplanar orientations with equal occupancy. A second dimethylformamide molecule is disordered about a twofold rotation axis.
[1] A. W. Addison,et al. Synthesis, structure, and spectroscopic properties of copper(II) compounds containing nitrogen–sulphur donor ligands; the crystal and molecular structure of aqua[1,7-bis(N-methylbenzimidazol-2′-yl)-2,6-dithiaheptane]copper(II) perchlorate , 1984 .
[2] S. Youngme,et al. Crystal structures, spectro-structural correlation and structural pathways of eight [Cu(dpyam)2(NCO)][Y] complexes (dpyam = di-2-pyridylamine), Y = Br- , CF3SO3- , BF4- · dpyam, Cl- · 4H2O, NO3- , PF6- , ClO4- and BPh4- , 2007 .